Kidney Care Partners Supports Trump's EO on Kidney Care

Kidney Care Partners – the nation's largest kidney coalition consisting of patient and patient advocacy groups, researchers and clinicians, providers and manufacturers – today praised the Trump Administration's announcement to increase focus and investment on the kidney disease epidemic in America, which affects more than 30 million Americans. The kidney care community welcomes the increased spotlight on promoting innovations in kidney care and improving patient outcomes, which provides a unique opportunity for partners in the public and private sectors to collaborate. KCP has valued its continued work with the White House, HHS and CMS on efforts to improve the lives of those living with kidney disease. Together, we brought the first value-based program, the ESRD Quality Incentive Program, to Medicare. Today provides us with another exciting opportunity.